Mark Green
Case file · Sep 30, 2024

Rep. Mark Green sold $NGL

Republican House $100,001 - $250,000 Joint NGL Energy Partners LP [energy]

What Happened Next

$NGL vs the S&P 500 from the trade date. A sale has an edge when the stock lags the market afterwards.

$NGL · 30 days
−9.3%
S&P 500, same days
+1.1% +10.4 pts edge
$NGL · 90 days
+6.9%
S&P 500, same days
+2.9% −4.0 pts edge
$NGL · 180 days
+0.9%
S&P 500, same days
−1.9% −2.8 pts edge
Return
−10%−5%0+5%+10%+15%

The Paper Trail

Trade date
Sep 30, 2024
Disclosed
Oct 7, 2024 (4 days)
Shuffle Score
8/100
Filing
Not linked

Mark Green's History in $NGL

DateTypeAmountOwner
May 17, 2023 Buy $50,001 - $100,000 Not disclosed
Jun 2, 2023 Buy $100,001 - $250,000 Not disclosed
Jun 8, 2023 Buy $100,001 - $250,000 Not disclosed
Aug 4, 2023 Buy $250,001 - $500,000 Not disclosed
Jan 11, 2024 Sell $100,001 - $250,000 Not disclosed
Jan 29, 2024 Sell $100,001 - $250,000 Not disclosed
Feb 26, 2024 Sell $50,001 - $100,000 Not disclosed
Mar 11, 2024 Sell $15,001 - $50,000 Not disclosed
Apr 1, 2024 Sell $100,001 - $250,000 Not disclosed
Apr 25, 2024 Sell $100,001 - $250,000 Not disclosed
May 7, 2024 Sell $250,001 - $500,000 Not disclosed
May 10, 2024 Sell $15,001 - $50,000 Not disclosed
Jun 3, 2024 Sell $100,001 - $250,000 Not disclosed
Jul 1, 2024 Sell $50,001 - $100,000 Not disclosed
Jul 24, 2024 Sell $15,001 - $50,000 Joint
Aug 5, 2024 Sell $50,001 - $100,000 Joint
Aug 28, 2024 Sell $50,001 - $100,000 Joint
Sep 17, 2024 Sell $1,001 - $15,000 Joint
Sep 30, 2024 Sell $100,001 - $250,000 Joint
Oct 16, 2024 Sell $50,001 - $100,000 Joint
Oct 24, 2024 Sell $50,001 - $100,000 Joint
Dec 3, 2024 Sell $15,001 - $50,000 Joint
Jan 2, 2025 Sell $15,001 - $50,000 Joint
Jan 28, 2025 Sell $50,001 - $100,000 Joint
Jan 30, 2025 Sell $500,001 - $1,000,000 Joint
Feb 3, 2025 Sell $250,001 - $500,000 Joint
Feb 18, 2025 Sell $100,001 - $250,000 Joint
Feb 28, 2025 Sell $15,001 - $50,000 Joint

Returns use split- and dividend-adjusted closes. Disclosures report ranges, not exact amounts. A well-timed trade is not evidence of wrongdoing. Methodology · Disclaimer